Abstract:Developing new drugs is costly, time-consuming, and risky. Drug-target affinity (DTA), indicating the binding capability between drugs and target proteins, is a crucial indicator for drug development. Accurately predicting interaction strength between new drug-target pairs by analyzing previous experiments aids in screening potential drug molecules, repurposing them, and developing safe and effective medicines. Existing computational models for DTA prediction rely on strings or single-graph neural networks, lacking consideration of protein structure and molecular semantic information, leading to limited accuracy. Our experiments demonstrate that string-based methods may overlook protein conformations, causing a high root mean square error (RMSE) of 3.584 in affinity due to a lack of spatial context. Single graph networks also underperform on topology features, with a 6% lower confidence interval (CI) for activity classification. Absent semantic information also limits generalization across diverse compounds, resulting in 18% increment in RMSE and 5% in misclassifications within quantifications study, restricting potential drug discovery. To address these limitations, we propose G-K BertDTA , a novel framework for accurate DTA prediction incorporating protein features, molecular semantic features, and molecular structural information. In this proposed model, we represent drugs as graphs, with a GIN employed to learn the molecular topological information. For the extraction of protein structural features, we utilize a DenseNet architecture. A knowledge-based BERT semantic model is incorporated to obtain rich pre-trained semantic embeddings, thereby enhancing the feature information. We extensively evaluated our proposed approach on the publicly available benchmark datasets (i.e., KIBA and Davis), and experimental results demonstrate the promising performance of our method, which consistently outperforms previous state-of-the-art approaches. Code is available at https://github.com/AmbitYuki/G-K-BertDTA .

Drug Target Path Discovery on Semantic Biomedical Big Data.

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Predicting drug target interactions using meta-path-based semantic network analysis

Network-Based Methods and Their Applications in Drug Discovery

The Use of Web Ontology Languages and Other Semantic Web Tools in Drug Discovery.

A uniﬁed framework for drug-target interaction prediction by semantic-guided meta-path method

Network based approach to drug discovery: a mini review.

Sdtnbi: an Integrated Network and Chemoinformatics Tool for Systematic Prediction of Drug-Target Interactions and Drug Repositioning

Relation Path Feature Embedding Based Convolutional Neural Network Method for Drug Discovery

SemaTyP: a Knowledge Graph Based Literature Mining Method for Drug Discovery.

Advanced Systems Biology Methods in Drug Discovery and Translational Biomedicine

Identifying targets for drug discovery using bioinformatics

An Efficient Drug-Target Interaction Mining Algorithm in Heterogeneous Biological Networks.

G-K BertDTA: A graph representation learning and semantic embedding-based framework for drug-target affinity prediction

Computational Drug Repositioning Using Meta-Path-based Semantic Network Analysis.

Discovery of Boolean Metabolic Networks: Integer Linear Programming Based Approach.

Network-based drug discovery by integrating systems biology and computational technologies

Some Remarks on Prediction of Drug-Target Interaction with Network Models

Recent Advances on the Network Models in Target-based Drug Discovery

Systems Approach to Pathogenic Mechanism of Type 2 Diabetes and Drug Discovery Design Based on Deep Learning and Drug Design Specifications

Title Discovery of Boolean Metabolic Networks : Integer LinearProgramming Based Approach